Innovative Thinking Could Make New Sickle Cell Treatments More Accessible
The cost of new gene-based sickle cell treatments isn’t the only barrier to access. Coming up with new ways to treat the whole disease—and person—could make treatment more equitable
The cost of new gene-based sickle cell treatments isn’t the only barrier to access. Coming up with new ways to treat the whole disease—and person—could make treatment more equitable
What's Your Reaction?
SIN
ScienceX Information Network (SIN) | ScienceX Innovations
![For 60+ years, respiratory syncytial virus (RSV) vaccines have evaded scientists. But now that's changed [Sponsored]](https://static.scientificamerican.com/sciam/cache/file/1E429511-D502-40E2-86CF47B90F8CC7D4_source.png?#)
